Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02407015
Other study ID # URMS 138673
Secondary ID
Status Completed
Phase N/A
First received March 30, 2015
Last updated October 12, 2015
Start date December 2014
Est. completion date May 2015

Study information

Verified date October 2015
Source University of Sheffield
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This study aims to examine the specific effect that 3D game play has on the control of the eyes horizontal movements. It will examine the youngest group of consumers this technology is marketed to, 7 to 11-year-olds and no children under 7 years of age will be recruited to this study as per Nintendo's hardware guidelines, which recommends that children under 7 years of age not play in 3D mode. It will examine the effect of playing in 3D for 30 minutes on horizontal fusional amplitudes compared with a control group playing in 2D for 30 minutes.


Description:

This study will be a prospective blind randomised control trial. The participants will be randomised into one study group, with participants playing a game in 3D; and a control group, with participants playing the same game in 2D. The study is blind due to the use of an independent assessor, reducing testing bias by ensuring that the tester does not know the randomisation results. The known dependant variables are the total horizontal fusional amplitudes at 1/3m and 6m and the independent variable is the use of 2D or 3D game play.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date May 2015
Est. primary completion date May 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 7 Years to 11 Years
Eligibility Inclusion Criteria:

- Male and female 7 to 11-year-olds with no prior history of binocular vision / ocular motility dysfunction.

Exclusion Criteria:

- Corrected visual acuity of less than 0.000 tested with SLT at 3m.

- Interocular visual acuity difference of 0.100 (tested with SLT) or greater, which could indicate the presence of Amblyopia.

- The presence of any manifest deviation (Tropia).

- Presence of any ocular motility dysfunction, which affects primary position.

- Reduced binocular convergence of 10 centimetres or less.

- Stereoacuity of less than 170" (this may indicate the presence of a microtropia or other undiagnosed pathology).

- Any prior or existing medical history of epilepsy or seizures.

- Any prior or existing medical history of repetitive strain injury.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Basic Science


Related Conditions & MeSH terms


Intervention

Other:
Nintendo 3DS gameplay


Locations

Country Name City State
United Kingdom Cambridge University Hospitals NHS trust Cambridge Cambridgeshire

Sponsors (1)

Lead Sponsor Collaborator
University of Sheffield

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in horizontal fusional amplitude Immediately following gameplay No
See also
  Status Clinical Trial Phase
Recruiting NCT05243277 - Oculomotor Response While Using a Helmet Display Incorporating an Accommodation-vergence Stress Reduction Algorithm
Withdrawn NCT05107791 - Effects of Stulln and Accommodative Training Phase 1/Phase 2
Completed NCT00402155 - Visual Discomfort and Reading N/A
Recruiting NCT02986555 - Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation N/A